bibliographic entry 12595362 [be/12595362]
https://w3id.org/oc/corpus/be/12595362

is a

• bibliographic reference

content

• Tveit, KM, Guren, T, Glimelius, B. Phase III trial of cetuximab with continuous or intermittent fluorouracil, leucovorin, and oxaliplatin (Nordic FLOX) versus FLOX alone in first-line treatment of metastatic colorectal cancer: the NORDIC-VII study, J Clin Oncol, 2012, 30, 1755, 1762, PMID: 22473155

references

• https://w3id.org/oc/corpus/br/1767429